title: Adherence to the 2013 Blood Cholesterol Guidelines in Patients With Diabetes at a PCMH: Comparison of Physician Only and Combination Physician/Pharmacist Visits.
abstract: The purpose of this study is to assess adherence to the 2013 blood cholesterol guideline in a population with diabetes based on the atherosclerotic cardiovascular (ASCVD) risk.
  
  
  
  Patients with diabetes were assessed to see whether they received the appropriate intensity statin therapy via chart review. Patients seen by a physician or pharmacist at CommUnityCare, a PCMH, from December 2013 to October 2014 were included in this retrospective study. The ASCVD risks were calculated to determine if the patients received appropriate intensity statin.
  
  
  
  A total of 583 patients met the inclusion criteria; there were 475 in the physician only group and 108 with additional pharmacist visits. Statin therapy was prescribed in 71% of patients in the physician group and 88% of patients in the pharmacist/physician group. The appropriate intensity statin was prescribed in 32% of patients in the physician group and 35% of patients in the pharmacist/physician group. The appropriate intensity statin in statin naïve patients was prescribed in 45% of the physician group and 50% of patients in the pharmacist/physician group.
  
  
  
  The proportion of patients prescribed an appropriate intensity statin did not differ between patients managed by physicians alone compared to those managed by pharmacists and physicians. Overall adherence to the 2013 blood cholesterol guidelines was 33%, and this measure can be used as a baseline assessment of current adherence with the guidelines.
authors.affiliation: University of Texas College of Pharmacy & CommUnityCare, Austin, Texas (Dr Hinds)
authors.forename: April
authors.initials: A
authors.lastname: Hinds
authors.affiliation: University of Texas at Austin, College of Pharmacy, Clinical Pharmacist at Sanofi, Austin, Texas (Dr Lopez)
authors.forename: Debra
authors.initials: D
authors.lastname: Lopez
authors.affiliation: University of Texas at Austin College of Pharmacy, Austin, Texas (Dr Rascati)
authors.forename: Karen
authors.initials: K
authors.lastname: Rascati
authors.affiliation: Clinical Pharmacist at CommUnityCare, Austin, Texas (Dr Jokerst, Dr Srinivasa).
authors.forename: Jason
authors.initials: J
authors.lastname: Jokerst
authors.affiliation: Clinical Pharmacist at CommUnityCare, Austin, Texas (Dr Jokerst, Dr Srinivasa).
authors.forename: Maaya
authors.initials: M
authors.lastname: Srinivasa
mesh_terms: D000328:Adult; D000368:Aged; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood; D048909:Diabetes Complications / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000097:blood*; D005260:Female; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000592:standards* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010595:Pharmacists / Q000706:statistics & numerical data; D010820:Physicians / Q000706:statistics & numerical data; D017410:Practice Guidelines as Topic; D012189:Retrospective Studies
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol